CTNM

Contineum Therapeutics, Inc. Class A Common StockNASDAQHealthcare

$13.44+0.00%ClosedMarket Cap: $501.8M

As of 2026-04-06

Valuation

P/E (TTM)

—

PEG

—

P/B

1.59

P/S

0.00

EV/EBITDA

-6.82

DCF Value

$2.40

FCF Yield

-11.1%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

-30.1%

ROA

-21.7%

ROIC

-25.3%

Income Statement

Period	Revenue	Gross Margin	Operating Income	Net Income	EPS	Dividend
Q4 2025	$0.00	-Infinity%	$-17.1M	$-15.2M	$-0.49	—
FY 2025	$0.00	-Infinity%	$-68.1M	$-60.0M	$-2.17	—
Q3 2025	$0.00	-Infinity%	$-14.9M	$-12.8M	$-0.45	—
Q2 2025	$0.00	-Infinity%	$-17.9M	$-16.0M	$-0.62	—
Q1 2025	$0.00	NaN%	$-18.1M	$-16.0M	$-0.62	—
Q4 2024	$0.00	NaN%	$84.7M	$-14.6M	$-0.65	—
FY 2024	$0.00	-Infinity%	$-50.9M	$-42.3M	$-2.18	—
Q3 2024	$0.00	NaN%	$-13.0M	$-10.3M	$-0.40	—
Q2 2024	$0.00	NaN%	$-10.9M	$-9.0M	$-0.35	—
Q1 2024	$0.00	NaN%	$-9.9M	$-8.4M	$-0.33	—
Q4 2023	$0.00	NaN%	$-9.7M	$-7.8M	$-0.31	—
FY 2023	$50.0M	100.0%	$-16.1M	$22.7M	$0.90	—